Simin Lu and Fumihiko Urano, Washington University School of Medicine (IMAGE)
Caption
Studying animal models and cells taken from patients with Wolfram syndrome, first author Simin Lu, PhD (left), and principal investigator Fumihiko Urano, MD, PhD, led a team that found the FDA-approved muscle relaxant dantrolene may be an effective treatment for the rare but devastating form of diabetes.
Credit
Robert Boston
Usage Restrictions
None
License
Licensed content